Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832026 · ClinicalTrials.gov registry record
Trans Nasal Insufflation for the Treatment of Snoring
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 11
- Enrollment target
NCT00832026: Completed study, sponsored by Johns Hopkins University.
NCT00832026 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832026 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea. People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repetitive closure of the throat. The most common form of treatment for sleep apnea is continuous positive airway pressure (CPAP) therapy. While CPAP therapy remains the simplest and most effective treatment for snoring and sleep apnea, patients have to wear a nasal mask throughout the night. For this reason, patients often have difficulty sticking to therapy. Participants enrolled in this study will spend 3-nights in a sleep laboratory. In all nights, the investigators will monitor your sleep and your breathing throughout the night. The investigators will apply several electrodes (sensors) to your scalp and face to monitor your sleep and breathing, and other sensors to your chest, abdomen, cheek, and a finger to monitor your breathing and oxygen level.
Interventions
- DEVICE Trans Nasal Insufflation (TNI) [nasal canula]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-03 |
What the finished NCT00832026 record still lists
NCT00832026 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Trans Nasal Insufflation (TNI) [nasal canula] is the first listed.
NCT00832026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00832026 about?
NCT00832026 is a clinical study titled "Trans Nasal Insufflation for the Treatment of Snoring". This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea. People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repe...
What is the current status of trial NCT00832026?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2004-07. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00832026?
The interventions under investigation include: Trans Nasal Insufflation (TNI) [nasal canula] (DEVICE).
Who is sponsoring clinical trial NCT00832026?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia